1. The circadian clock circuitry and the AHR signaling pathway in physiology and pathology
   George Anderson et al, 2013, Biochemical Pharmacology CrossRef
2. Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma
   F.Q. Yang et al, 2014, Actas Urológicas Españolas (English Edition) CrossRef
3. Clinical Significance of Soluble Major Histocompatibility Complex Class I Chain-related A in Renal Cell Carcinoma Patients
   Yu Qiu et al, 2013, Asian Pacific Journal of Cancer Prevention CrossRef
4. Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications
   G. Chitadze et al, 2013, Scandinavian Journal of Immunology CrossRef
5. NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma
   Cinzia Fionda et al, 2015, BioMed Research International CrossRef
6. Natural killer cells in the treatment of glioblastoma: Diverse antitumor functions and potential clinical applications
   Barbara Breznik et al, 2023, NK Cells in Cancer Immunotherapy: Successes and Challenges CrossRef
7. Matrix metallopeptidase 2 (MMP2) media la eliminación de MHC class I polypeptide-related sequence A (MICA) en el cáncer de células renales
   F.Q. Yang et al, 2014, Actas Urológicas Españolas CrossRef
8. Transient plasticity response is regulated by histone deacetylase inhibitor in oxygen–glucose deprivation condition
   Ming-Chia Chu et al, 2023, Pharmacological Reports CrossRef
9. Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in Helicobacter pylori infection
   Margit Anthofer et al, 2024, Frontiers in Immunology CrossRef
10. Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells
    KOJI YAMANEGI et al, 2015, International Journal of Oncology CrossRef
11. Levels of Matrix Metalloproteinase 9 Are Elevated in Persons With Schizophrenia or Bipolar Disorder: The Role of Modifiable Factors
    Faith Dickerson et al, 2023, Biological Psychiatry Global Open Science CrossRef
12. Molecular signature of extracellular matrix pathology in schizophrenia
    Harry Pantazopoulos et al, 2021, European Journal of Neuroscience CrossRef
13. Natural Killer Cells in Cancer and Cancer Immunotherapy
    Hans Raskov et al, 2021, Cancer Letters CrossRef
14. Secretory pathways generating immunosuppressive NKG2D ligands: New targets for therapeutic intervention
    Aroa Baragaño Raneros et al, 2014, OncoImmunology CrossRef
15. Persistently elevated soluble MHC class I polypeptide-related sequence A and transforming growth factor-β1 levels are poor prognostic factors in head and neck squamous cell carcinoma after definitive chemoradiotherapy
    Jenny Ling-Yu Chen et al, 2018, PLOS ONE CrossRef
16. HDAC inhibitors and their potential applications to glioblastoma therapy
    Eleni Adamopoulou et al, 2013, OncoImmunology CrossRef
17. Genetics, genomics, and evolutionary biology of NKG2D ligands
    Raphael Carapito et al, 2015, Immunological Reviews CrossRef
18. Glycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune Recognition
    Sheila López-Cobo et al, 2016, Frontiers in Cell and Developmental Biology CrossRef
19. Major Histocompatibility Complex Class I Chain–Related A and B (MICA and MICB) Gene, Allele, and Haplotype Associations With Dengue Infections in Ethnic Thais
    Panpimon Luangtrakool et al, 2020, The Journal of Infectious Diseases CrossRef
20. Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion
    Linda Ziani et al, 2017, Oncotarget CrossRef